{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T02:04:31Z","timestamp":1783476271933,"version":"3.55.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T00:00:00Z","timestamp":1717977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T00:00:00Z","timestamp":1717977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s11845-024-03730-5","type":"journal-article","created":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T04:02:00Z","timestamp":1717992120000},"page":"2269-2279","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Establishment of a scoring model for predicting clinical outcomes in patients with unilateral primary aldosteronism after superselective adrenal artery embolization"],"prefix":"10.1007","volume":"193","author":[{"given":"Tao","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jindong","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinquan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jixin","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0493-3118","authenticated-orcid":false,"given":"Peijian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,10]]},"reference":[{"issue":"11","key":"3730_CR1","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s41574-022-00730-2","volume":"18","author":"AF Turcu","year":"2022","unstructured":"Turcu AF, Yang J, Vaidya A (2022) Primary aldosteronism-a multidimensional syndrome. Nat Rev Endocrinol 18(11):665\u2013682. https:\/\/doi.org\/10.1038\/s41574-022-00730-2","journal-title":"Nat Rev Endocrinol"},{"issue":"14","key":"3730_CR2","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1161\/CIRCULATIONAHA.122.062349","volume":"147","author":"T Naito","year":"2023","unstructured":"Naito T, Inoue K, Sonehara K et al (2023) Genetic risk of primary aldosteronism and its contribution to hypertension: a cross-ancestry meta-analysis of genome-wide association studies. Circulation 147(14):1097\u20131109. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.122.062349","journal-title":"Circulation"},{"issue":"4","key":"3730_CR3","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1161\/HYPERTENSIONAHA.121.18761","volume":"79","author":"JW Funder","year":"2022","unstructured":"Funder JW, Carey RM (2022) Primary aldosteronism: where are we now? where to from here? Hypertension 79(4):726\u2013735. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.121.18761","journal-title":"Hypertension"},{"issue":"10","key":"3730_CR4","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1097\/HJH.0000000000002510","volume":"38","author":"P Mulatero","year":"2020","unstructured":"Mulatero P, Monticone S, Deinum J et al (2020) Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension. J Hypertens 38(10):1919\u20131928. https:\/\/doi.org\/10.1097\/HJH.0000000000002510","journal-title":"J Hypertens"},{"key":"3730_CR5","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1146\/annurev-med-042921-100438","volume":"74","author":"JB Cohen","year":"2023","unstructured":"Cohen JB, Bancos I, Brown JM et al (2023) Primary aldosteronism and the role of mineralocorticoid receptor antagonists for the heart and kidneys. Annu Rev Med 74:217\u2013230. https:\/\/doi.org\/10.1146\/annurev-med-042921-100438","journal-title":"Annu Rev Med"},{"issue":"1","key":"3730_CR6","doi-asserted-by":"publisher","first-page":"R19","DOI":"10.1530\/EJE-17-0990","volume":"179","author":"TA Williams","year":"2018","unstructured":"Williams TA, Reincke M (2018) MANAGEMENT OF ENDOCRINE DISEASE: Diagnosis and management of primary aldosteronism: the Endocrine Society guideline 2016 revisited. Eur J Endocrinol 179(1):R19\u2013R29. https:\/\/doi.org\/10.1530\/EJE-17-0990","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"3730_CR7","doi-asserted-by":"publisher","first-page":"e1400","DOI":"10.1210\/clinem\/dgaa706","volume":"106","author":"Y Ohno","year":"2021","unstructured":"Ohno Y, Naruse M, Beuschlein F et al (2021) Adrenal venous sampling-guided adrenalectomy rates in primary aldosteronism: results of an international cohort (AVSTAT). J Clin Endocrinol Metab 106(3):e1400\u2013e1407. https:\/\/doi.org\/10.1210\/clinem\/dgaa706","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"3730_CR8","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1161\/HYPERTENSIONAHA.119.13463","volume":"74","author":"GP Rossi","year":"2019","unstructured":"Rossi GP, Rossitto G, Amar L et al (2019) Clinical outcomes of 1625 patients with primary aldosteronism subtyped with adrenal vein sampling. Hypertension 74(4):800\u2013808. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.119.13463","journal-title":"Hypertension"},{"key":"3730_CR9","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ijcard.2015.05.127","volume":"200","author":"M Lainscak","year":"2015","unstructured":"Lainscak M, Pelliccia F, Rosano G et al (2015) Safety profile of mineralocorticoid receptor antagonists: spironolactone and eplerenone. Int J Cardiol 200:25\u201329. https:\/\/doi.org\/10.1016\/j.ijcard.2015.05.127","journal-title":"Int J Cardiol"},{"issue":"2","key":"3730_CR10","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1161\/HYPERTENSIONAHA.120.16449","volume":"77","author":"R Nakamaru","year":"2021","unstructured":"Nakamaru R, Yamamoto K, Akasaka H et al (2021) Sex differences in renal outcomes after medical treatment for bilateral primary aldosteronism. Hypertension 77(2):537\u2013545. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.120.16449","journal-title":"Hypertension"},{"issue":"7","key":"3730_CR11","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1161\/CIRCULATIONAHA.121.054318","volume":"144","author":"Z Zhao","year":"2021","unstructured":"Zhao Z, Liu X, Zhang H et al (2021) Catheter-based adrenal ablation remits primary aldosteronism: a randomized medication-controlled trial. Circulation 144(7):580\u2013582. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.121.054318","journal-title":"Circulation"},{"issue":"12","key":"3730_CR12","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1093\/ajh\/hpac105","volume":"35","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Liu Q, Wang X et al (2022) Adrenal ablation versus mineralocorticoid receptor antagonism for the treatment of primary aldosteronism: a single-center prospective cohort study. Am J Hypertens 35(12):1014\u20131023. https:\/\/doi.org\/10.1093\/ajh\/hpac105","journal-title":"Am J Hypertens"},{"issue":"5","key":"3730_CR13","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1038\/s41440-023-01236-8","volume":"46","author":"J Qiu","year":"2023","unstructured":"Qiu J, Li N, Xiong HL et al (2023) Superselective adrenal arterial embolization for primary aldosteronism without lateralized aldosterone secretion: an efficacy and safety, proof-of-principle study. Hypertens Res 46(5):1297\u20131310. https:\/\/doi.org\/10.1038\/s41440-023-01236-8","journal-title":"Hypertens Res"},{"issue":"9","key":"3730_CR14","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S2213-8587(17)30135-3","volume":"5","author":"TA Williams","year":"2017","unstructured":"Williams TA, Lenders JWM, Mulatero P et al (2017) Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. Lancet Diabetes Endocrinol 5(9):689\u2013699. https:\/\/doi.org\/10.1016\/S2213-8587(17)30135-3","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"3730_CR15","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1097\/SLA.0b013e318165c075","volume":"247","author":"R Zarnegar","year":"2008","unstructured":"Zarnegar R, Young WF Jr, Lee J et al (2008) The aldosteronoma resolution score: predicting complete resolution of hypertension after adrenalectomy for aldosteronoma. Ann Surg 247(3):511\u2013518. https:\/\/doi.org\/10.1097\/SLA.0b013e318165c075","journal-title":"Ann Surg"},{"issue":"12","key":"3730_CR16","doi-asserted-by":"publisher","first-page":"dgaa634","DOI":"10.1210\/clinem","volume":"105","author":"Y Yang","year":"2020","unstructured":"Yang Y, Williams TA, Song Y et al (2020) Nomogram-based preoperative score for predicting clinical outcome in unilateral primary aldosteronism. J Clin Endocrinol Metab 105(12):dgaa634. https:\/\/doi.org\/10.1210\/clinem","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"3730_CR17","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","volume":"101","author":"JW Funder","year":"2016","unstructured":"Funder JW, Carey RM, Mantero F et al (2016) The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 101(5):1889\u20131916. https:\/\/doi.org\/10.1210\/jc.2015-4061","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"3730_CR18","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/S2213-8587(21)00210-2","volume":"9","author":"M Reincke","year":"2021","unstructured":"Reincke M, Bancos I, Mulatero P et al (2021) Diagnosis and treatment of primary aldosteronism. Lancet Diabetes Endocrinol 9(12):876\u2013892. https:\/\/doi.org\/10.1016\/S2213-8587(21)00210-2","journal-title":"Lancet Diabetes Endocrinol"},{"key":"3730_CR19","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12902-021-00685-x","volume":"21","author":"J Wan","year":"2021","unstructured":"Wan J, Ran F, Xia S et al (2021) Feasibility and effectiveness of a single-catheter approach for adrenal vein sampling in patients with primary aldosteronism. BMC Endocr Disord 21:22. https:\/\/doi.org\/10.1186\/s12902-021-00685-x","journal-title":"BMC Endocr Disord"},{"key":"3730_CR20","doi-asserted-by":"publisher","unstructured":"Wan J, Wang X, Liu S et al (2023) A modified single-catheter approach for improving adrenal venous sampling in patients with primary aldosteronism. J Vasc Access:11297298231213669. https:\/\/doi.org\/10.1177\/11297298231213669","DOI":"10.1177\/11297298231213669"},{"key":"3730_CR21","doi-asserted-by":"publisher","unstructured":"ElSayed NA, Aleppo G, Aroda VR et al  2. Classification and diagnosis of diabetes: standards of care in diabetes-2023. Diabetes Care 46(Suppl 1):S19\u2013S40. https:\/\/doi.org\/10.2337\/dc23-S002","DOI":"10.2337\/dc23-S002"},{"issue":"33","key":"3730_CR22","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj","volume":"39","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W et al (2018) 2018 ESC\/ESH guidelines for the management of arterial hypertension. Eur Heart J 39(33):3021\u20133104. https:\/\/doi.org\/10.1093\/eurheartj","journal-title":"Eur Heart J"},{"issue":"3","key":"3730_CR23","doi-asserted-by":"publisher","first-page":"182","DOI":"10.11909\/j.issn.1671-5411.2019.03.014","volume":"16","author":"Joint Committee for Guideline Revision","year":"2019","unstructured":"Joint Committee for Guideline Revision (2019) 2018 Chinese guidelines for prevention and treatment of hypertension-a report of the revision committee of Chinese guidelines for prevention and treatment of hypertension. J Geriatr Cardiol 16(3):182\u2013241. https:\/\/doi.org\/10.11909\/j.issn.1671-5411.2019.03.014","journal-title":"J Geriatr Cardiol"},{"issue":"5","key":"3730_CR24","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1097\/SLA.0000000000005639","volume":"276","author":"DPD Suurd","year":"2022","unstructured":"Suurd DPD, Vorselaars WMCM, Van Beek DJ et al (2022) Assessing outcomes after adrenalectomy for primary aldosteronism-early is accurate: retrospective cohort study. Ann Surg 276(5):929\u2013934. https:\/\/doi.org\/10.1097\/SLA.0000000000005639","journal-title":"Ann Surg"},{"key":"3730_CR25","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1186\/s12933-023-02060-7","volume":"22","author":"S Tao","year":"2023","unstructured":"Tao S, Yu L, Li J et al (2023) Prognostic value of triglyceride-glucose index in patients with chronic coronary syndrome undergoing percutaneous coronary intervention. Cardiovasc Diabetol 22:322. https:\/\/doi.org\/10.1186\/s12933-023-02060-7","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3730_CR26","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1186\/s12916-023-03121-0","volume":"21","author":"Z Wang","year":"2023","unstructured":"Wang Z, Li Y, He Z et al (2023) Predictive model for epileptogenic tubers from all tubers in patients with tuberous sclerosis complex based on 18F-FDG PET: an 8-year single-centre study. BMC Med 21(1):500. https:\/\/doi.org\/10.1186\/s12916-023-03121-0","journal-title":"BMC Med"},{"issue":"1","key":"3730_CR27","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41440-022-01034-8","volume":"46","author":"F Sun","year":"2023","unstructured":"Sun F, Liu X, Zhang H et al (2023) Catheter-based adrenal ablation: an alternative therapy for patients with aldosterone-producing adenoma. Hypertens Res 46(1):91\u201399. https:\/\/doi.org\/10.1038\/s41440-022-01034-8","journal-title":"Hypertens Res"},{"issue":"11","key":"3730_CR28","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1210\/js.2019-00295","volume":"3","author":"M Morisaki","year":"2019","unstructured":"Morisaki M, Kurihara I, Itoh H et al (2019) Predictors of clinical success after surgery for primary aldosteronism in the Japanese nationwide cohort. J Endocr Soc 3(11):2012\u20132022. https:\/\/doi.org\/10.1210\/js.2019-00295","journal-title":"J Endocr Soc"},{"issue":"1","key":"3730_CR29","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.surg.2020.04.017","volume":"169","author":"JW Thiesmeyer","year":"2021","unstructured":"Thiesmeyer JW, Ullmann TM, Greenberg J et al (2021) Hypertension resolution after adrenalectomy for primary hyperaldosteronism: which is the best predictive model? Surgery 169(1):133\u2013137. https:\/\/doi.org\/10.1016\/j.surg.2020.04.017","journal-title":"Surgery"},{"issue":"3","key":"3730_CR30","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/s41440-023-01554-x","volume":"47","author":"L Marzano","year":"2024","unstructured":"Marzano L, Ronco C (2024) Clinical and biochemical outcomes after adrenalectomy for primary aldosteronism in tertiary and quaternary referral centers: data from SOPRANO study. Hypertens Res 47(3):721\u2013734. https:\/\/doi.org\/10.1038\/s41440-023-01554-x","journal-title":"Hypertens Res"},{"issue":"2","key":"3730_CR31","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1161\/HYPERTENSIONAHA.122.17952","volume":"80","author":"CT Barris","year":"2023","unstructured":"Barris CT, Faulkner JL, Belin de Chantem\u00e8le EJ (2023) Salt sensitivity of blood pressure in women. Hypertension 80(2):268\u2013278. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.122.17952","journal-title":"Hypertension"},{"issue":"6","key":"3730_CR32","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1097\/SLA.0000000000003200","volume":"272","author":"J Burrello","year":"2020","unstructured":"Burrello J, Burrello A, Stowasser M et al (2020) The primary aldosteronism surgical outcome score for the prediction of clinical outcomes after adrenalectomy for unilateral primary aldosteronism. Ann Surg 272(6):1125\u20131132. https:\/\/doi.org\/10.1097\/SLA.0000000000003200","journal-title":"Ann Surg"},{"issue":"1","key":"3730_CR33","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s12020-022-03168-8","volume":"79","author":"M Moustaki","year":"2023","unstructured":"Moustaki M, Paschou SA, Vakali EC et al (2023) Secondary diabetes mellitus due to primary aldosteronism. Endocrine 79(1):17\u201330. https:\/\/doi.org\/10.1007\/s12020-022-03168-8","journal-title":"Endocrine"},{"issue":"5","key":"3730_CR34","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1161\/HYPERTENSIONAHA.119.13922","volume":"75","author":"GK Adler","year":"2020","unstructured":"Adler GK, Murray GR, Turcu AF et al (2020) Primary aldosteronism decreases insulin secretion and increases insulin clearance in humans. Hypertension 75(5):1251\u20131259. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.119.13922","journal-title":"Hypertension"},{"issue":"7","key":"3730_CR35","doi-asserted-by":"publisher","first-page":"dgaa177","DOI":"10.1210\/clinem\/dgaa177","volume":"105","author":"A Saiki","year":"2020","unstructured":"Saiki A, Otsuki M, Tamada D et al (2020) Diabetes mellitus itself increases cardio-cerebrovascular risk and renal complications in primary aldosteronism. J Clin Endocrinol Metab 105(7):dgaa177. https:\/\/doi.org\/10.1210\/clinem\/dgaa177","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"3730_CR36","doi-asserted-by":"publisher","first-page":"dgz293","DOI":"10.1210\/clinem\/dgz293","volume":"105","author":"Y Hu","year":"2020","unstructured":"Hu Y, Zhang J, Liu W et al (2020) Determining the prevalence of primary aldosteronism in patients with new-onset type 2 diabetes and hypertension. J Clin Endocrinol Metab 105(4):dgz293. https:\/\/doi.org\/10.1210\/clinem\/dgz293","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"3730_CR37","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12902-023-01356-9","volume":"23","author":"S Yang","year":"2023","unstructured":"Yang S, Wang G, Li N et al (2023) The outcomes of transcatheter adrenal ablation in patients with primary aldosteronism: a systematic review and meta-analysis. BMC Endocr Disord 23(1):103. https:\/\/doi.org\/10.1186\/s12902-023-01356-9","journal-title":"BMC Endocr Disord"},{"issue":"2","key":"3730_CR38","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1148\/radiol.2272011798","volume":"227","author":"H Hokotate","year":"2003","unstructured":"Hokotate H, Inoue H, Baba Y et al (2003) Aldosteronomas: experience with superselective adrenal arterial embolization in 33 cases. Radiology 227(2):401\u2013406. https:\/\/doi.org\/10.1148\/radiol.2272011798","journal-title":"Radiology"}],"container-title":["Irish Journal of Medical Science (1971 -)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-024-03730-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11845-024-03730-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-024-03730-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T11:22:53Z","timestamp":1727954573000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11845-024-03730-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,10]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["3730"],"URL":"https:\/\/doi.org\/10.1007\/s11845-024-03730-5","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"value":"0021-1265","type":"print"},{"value":"1863-4362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,10]]},"assertion":[{"value":"8 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in accordance with the Declaration of Helsinki and was approved by the Ethics Committee of the First Affiliated Hospital of Chengdu Medical College (approval number: 2020CYFYHEC-BA-75). Trail registration: ChiCTR2100045896.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from all the\u00a0participants before enrollment.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"This is not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}